Escalon Medical Corp. ESMC

Q4 FY2026 · ended Jun 30, 2026 · Revenue $3.86M, +48.0% YoY · Filed Oct 13, 2026

Escalon Medical Corp. (ESMC) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In Q4 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $3.9 million and net income of $1.8 million. Free cash flow was -$251,180. As of Jun 30, 2026 it held $3.1 million in cash and investments and $835,865 in total debt.

Revenue
$3.86M
+48.0% vs prior quarter
Net income
$1.78M
+569.1% vs year-ago quarter
Operating cash flow
$-251,180
-1693.8% vs year-ago quarter
Free cash flow
$-251,180
-2214.3% vs year-ago quarter
EPS
$0.06
+523.5% vs year-ago quarter
Dividend per share
None
Shares outstanding
7.42M
+0.0% vs year-ago quarter
Net cash
$2.23M
Q4 FY2026
Operating margin
14.7%
Q4 FY2026

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
ESMC (OTC)
Fiscal year ends
June 30
Incorporated in
PA
Headquarters
Wayne, PA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
862668

Other Electromedical & Electrotherapeutic Apparatus companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q4 FY2026
Jun 30, 2026
Q3 FY2026
Mar 31, 2026
Q2 FY2026
Dec 31, 2025
Q1 FY2026
Sep 30, 2025
Q4 FY2025
Jun 30, 2025
Revenue
$3.9M
$2.6M
$3.6M
$2.7M
—
Operating income
$568,511
-$419,263
$98,738
-$202,751
-$371,769
Net income
$1.8M
$2.4M
$97,677
-$239,852
-$379,751
Diluted EPS
$0.06
$0.16
$0.01
-$0.03
-$0.01
Operating cash flow
-$251,180
$280,983
-$517,415
$85,008
$15,760
Free cash flow
-$251,180
$280,983
-$517,415
$80,587
$11,880
Total assets
$9.1M
$7.5M
$5.0M
—
$5.0M
Total liabilities
$3.2M
$3.4M
$3.2M
$2.9M
$3.1M
Stockholders' equity
$5.9M
$4.1M
$1.8M
$1.7M
$1.9M
Cash and investments
$3.1M
$3.3M
$337,434
$615,791
$545,835
Total debt
$835,865
$870,814
$579,437
$236,803
$254,536

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-K Annual report Oct 13, 2026 Jun 30, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
10-Q Quarterly report Feb 17, 2026 Dec 31, 2025
8-K Current report
Material agreement, Acquisition or sale of assets
Jan 29, 2026 Jan 23, 2026
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
10-K Annual report Sep 29, 2025 Jun 30, 2025

Source: SEC EDGAR filings. This is company-reported data, not investment advice.